Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1

By Sochaj-Gregorczyk Alicja M.   Ludzia Patryk   Kozdrowska Emilia   Jakimowicz Piotr   Sokolowska-Wedzina Aleksandra   Otlewski Jacek  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1688-1688

MDPI

Access to resources Recommend Favorite

Development and Characterization of a Humanized Anti-HER2 Antibody HuA21 with Potent Anti-Tumor Properties in Breast Cancer Cells

By Li Ruilin   Hu Siyi   Chang Yan   Zhang Zhihui   Zha Zhao   Huang Hui   Shen Guodong   Liu Jing   Song Lihua   Wei Wei  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 563-563

MDPI

Access to resources Recommend Favorite

Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer

By Li Jianzong   Wang Haiyang   Li Junjie   Bao Jinku   Wu Chuanfang  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1055-1055

MDPI

Access to resources Recommend Favorite

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

By Gijs Marlies   Penner Gregory   Blackler Garth B.   Impens Nathalie R.E.N.   Baatout Sarah   Luxen André   Aerts An M.  

Pharmaceuticals, Vol. 9, Iss. 2, 2016-05 ,pp. : 29-29

MDPI

Access to resources Recommend Favorite

Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype

By Caggiari Laura   Miolo Gianmaria   Buonadonna Angela   Basile Debora   Santeufemia Davide A.   Cossu Antonio   Palmieri Giuseppe   De Zorzi Mariangela   Fornasarig Mara   Alessandrini Lara   Canzonieri Vincenzo   Lo Re Giovanni   Puglisi Fabio   Steffan Agostino   Cannizzaro Renato   De Re Valli  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 47-47

MDPI

Access to resources Recommend Favorite